Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03793166
What this trial is testing

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+6 more
National Cancer Institute (NCI) 1,175
Testing effectiveness (Phase 2)Study completedNCT00045279
What this trial is testing

PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01689662
What this trial is testing

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Endocyte 40
Testing effectiveness (Phase 2)Ended earlyNCT02626754
What this trial is testing

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Who this might be right for
Renal Cell Carcinoma
vghtpe user 13
Large-scale testing (Phase 3)Study completedNCT00003376
What this trial is testing

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 330
Not applicableStudy completedNCT05858749
What this trial is testing

Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 494
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableStudy completedNCT02499458
What this trial is testing

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

Who this might be right for
Clear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial Cells+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 44
Early research (Phase 1)Study completedNCT02035358
What this trial is testing

Immunotherapy Study for Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Clear-cell Renal CancerRecurrent Renal Cell Carcinoma+2 more
NewLink Genetics Corporation 18
Testing effectiveness (Phase 2)Ended earlyNCT01160445
What this trial is testing

Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer

Who this might be right for
Metastatic MelanomaMetastatic Renal Cancer
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Ended earlyNCT00277316
What this trial is testing

Study of XL999 in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Symphony Evolution, Inc. 11
Post-approval studies (Phase 4)Study completedNCT02555748
What this trial is testing

Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Cancer
Institut Claudius Regaud 47
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Testing effectiveness (Phase 2)Study completedNCT00835978
What this trial is testing

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Pfizer 213
Early research (Phase 1)Study completedNCT03107663
What this trial is testing

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

Who this might be right for
Positron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more
ImaginAb, Inc. 15
Not applicableActive Not RecruitingNCT01582204
What this trial is testing

Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cancer
Memorial Sloan Kettering Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT01064310
What this trial is testing

Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 169
Testing effectiveness (Phase 2)Study completedNCT00664326
What this trial is testing

A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC

Who this might be right for
Carcinoma, Renal Cell
Bayer 49
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Next Page